Endo Operations Company Profile

✉ Email this page to a colleague

ENDO OPERATIONS has one hundred and twenty approved drugs.

There are twenty-four US patents protecting ENDO OPERATIONS drugs. There is one tentative approval on ENDO OPERATIONS drugs.

There are sixty-one patent family members on ENDO OPERATIONS drugs in thirty-eight countries and two hundred and seventy-three supplementary protection certificates in seventeen countries.

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Endo Operations	CLONAZEPAM	clonazepam	TABLET, ORALLY DISINTEGRATING;ORAL	077171-004	Aug 3, 2005	AB	RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Endo Operations	VASOSTRICT	vasopressin	SOLUTION;INTRAVENOUS	204485-006	Apr 12, 2023		DISCN	Yes	No	10,010,575	⤷ Sign Up				⤷ Sign Up
Endo Operations	DEXMETHYLPHENIDATE HYDROCHLORIDE	dexmethylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	202842-002	Nov 30, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Endo Operations	BENZTROPINE MESYLATE	benztropine mesylate	TABLET;ORAL	040715-001	Aug 27, 2007	AA	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Endo Operations	TESTIM	testosterone	GEL;TRANSDERMAL	021454-001	Oct 31, 2002	7,608,610	⤷ Sign Up
Endo Operations	FROVA	frovatriptan succinate	TABLET;ORAL	021006-001	Nov 8, 2001	5,616,603	⤷ Sign Up
Endo Operations	FORTESTA	testosterone	GEL, METERED;TRANSDERMAL	021463-001	Dec 29, 2010	6,579,865	⤷ Sign Up
Endo Operations	FROVA	frovatriptan succinate	TABLET;ORAL	021006-001	Nov 8, 2001	5,637,611	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Gel	10 mg/actuation	➤ Subscribe	2012-08-14
➤ Subscribe	Injection	100 mg/mL, 2.5 mL vials	➤ Subscribe	2007-09-24
➤ Subscribe	Injection	250 mg/mL	➤ Subscribe	2014-06-11
➤ Subscribe	Injection	20 units/mL, 1 mL	➤ Subscribe	2018-03-23
➤ Subscribe	Gel	1%	➤ Subscribe	2008-08-21
➤ Subscribe	Injection	1 mg/mL, 50 mL vials	➤ Subscribe	2011-12-16
➤ Subscribe	Injection	1 mg/mL ampules	➤ Subscribe	2016-03-09
➤ Subscribe	Tablets	2.5 mg	➤ Subscribe	2011-03-09

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2673237	1990016-6	Sweden	⤷ Sign Up	PRODUCT NAME: SODIUM ZIRCONIUM CYCLOSILICATE; REG. NO/DATE: EU/1/17/1173 20180326
2269603	PA2015041	Lithuania	⤷ Sign Up	PRODUCT NAME: EVEROLIMUSUM; REGISTRATION NO/DATE: EU/1/09/538/001, EU/1/09/538/003, EU/1/09/538/004, EU/1/09/538/006-010 20120723
0788511	08C0028	France	⤷ Sign Up	PRODUCT NAME: MICAFUNGINE; REGISTRATION NO/DATE: EU/1/08/448/001-002 20080425
3342411	LUC00148	Luxembourg	⤷ Sign Up	PRODUCT NAME: EVEROLIMUS; AUTHORISATION NUMBER AND DATE: EU/1/09/538/001-008 20110830
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.